Status: Recruiting
Safety and Feasibility Study: Transcatheter Valve Repair in Severe Symptomatic Functional Tricuspid Regurgitation
The goal of this clinical trial is to evaluate the safety and technical success of the Tangent Tricuspid Annular Therapy System in patients with severe, symptomatic functional tricuspid regurgitation.
Participants needed: 25
Trial details
Age: 18-90Biological sex: AllType: InterventionalSponsor: Tangent Cardiovascular Inc.Updated: Aug 24, 2025Locations: 1
Eligibility criteria
18-90 years old at the time of consent [+5]
Estimated life expectancy of less than 12 months [+26]